Details of the SBP
| General Information of Synthetic Binding Protein (SBP) (ID: SBP000370) | ||||||
|---|---|---|---|---|---|---|
| SBP Name |
Affimer anti-SARS-CoV-2
|
|||||
| Synonyms |
Anti-SARS-COV-2 Affimer
|
|||||
| Design Method | Traditional methods (Site-directed mutagenesis and/or Directed evolution) | |||||
| Highest Status | Research | |||||
| Protein Scaffold Information of This SBP | ||||||
|---|---|---|---|---|---|---|
| Scaffold ID | PS006 | [1] | ||||
| Scaffold Name | Affimer | |||||
| Scaffold Class | Non-Antibody | |||||
| Fold Type | One Alpha-Helix + Beta-Sheets+ Loops | |||||
| Binding Target(s) of This SBP (BTS) |
|---|
| BTS Name | Details | Mechanism | Application | Affinity | Research Organization | Ref |
|---|---|---|---|---|---|---|
| Spike glycoprotein | Binder | SARS-CoV-2 infection (COVID-19) [ICD-11: XN109] | N.A. | Avacta Group plc | [1] | |